This observation was further validated by GSEA which revealed an enrichment of genes whose expression in primary tumors of estrogen receptor positive (ER+) breast cancer positively correlates with developing distant metastases are enriched in patients with low miR-644a signature scores from GSE58644 (Supplementary Table S3). The gene discussed is ESR1; the disease is breast cancer.